Suppr超能文献

淋巴结活检在HIV感染患者的诊断和预后评估中的应用

Lymph node biopsy in the diagnostic and prognostic assessment of patients with HIV infection.

作者信息

Badellino F, Moresco L, Gipponi M, Cafiero F, Perasole A, Pagano G, Alessandrini A, Nicolò G

机构信息

Divisione di Oncologia Chirurgica, Istituto Nazionale per la Ricerca sul Cancro, Genova.

出版信息

Ital J Surg Sci. 1989;19(3):217-24.

PMID:2807838
Abstract

Thirty-three anti-HIV positive patients with persistent generalized lymphadenopathy (PGL) who underwent lymph-node biopsy were studied to assess the diagnostic and prognostic relations existing between clinical, histological and laboratory findings. Patients were also examined for known risk factors, laboratory and bacteriological tests, and mononuclear cell surface marker analysis. 4 histological types were identified according to Ràcz's classification. At biopsy, there were 21 cases of LAS (64%), 6 cases of ARC (18%) and 6 cases of AIDS (18%); a clear prevalence of type 1 was evidenced in LAS/ARC patients, while only type 4 was present in the AIDS group. An ARC type 3 patient developed manifest AIDS within 13 months from biopsy. These results suggest that anti-HIV positive asymptomatic patients with PGL apparently do not require lymph node biopsy, as none of them showed histologic findings suggestive of opportunistic infections, malignant lymphoma or Kaposi's sarcoma. On the contrary, lymph node biopsy can play a diagnostic and prognostic role in anti-HIV negative subjects with PGL, and in ARC and AIDS patients.

摘要

对33例接受淋巴结活检的持续性全身性淋巴结肿大(PGL)的抗HIV阳性患者进行了研究,以评估临床、组织学和实验室检查结果之间存在的诊断和预后关系。还对患者进行了已知危险因素、实验室和细菌学检查以及单核细胞表面标志物分析。根据拉茨分类法确定了4种组织学类型。活检时,有21例LAS(64%)、6例ARC(18%)和6例AIDS(18%);LAS/ARC患者中1型明显占优势,而AIDS组仅出现4型。1例ARC 3型患者在活检后13个月内发展为明显的AIDS。这些结果表明,抗HIV阳性且无症状的PGL患者显然不需要进行淋巴结活检,因为他们中没有一人表现出提示机会性感染、恶性淋巴瘤或卡波西肉瘤的组织学发现。相反,淋巴结活检在抗HIV阴性的PGL患者以及ARC和AIDS患者中可发挥诊断和预后作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验